Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject

被引：6

作者：

Bonora, Stefano ^{[1
,2
]}

Calcagno, Andrea ^{[2
]}

Fontana, Silvia ^{[2
]}

D'Avolio, Antonio ^{[2
]}

Siccardi, Marco ^{[2
]}

Gobbi, Federico ^{[2
]}

Di Perri, Giovanni ^{[2
]}

机构：

[1] Univ Turin, Osped Amedeo Savoia, Clin Malattie Infett, I-10149 Turin, Italy

[2] Univ Turin, Dept Infect Dis, Turin, Italy

来源：

CLINICAL INFECTIOUS DISEASES | 2007年 / 45卷 / 12期

关键词：

D O I：

10.1086/523722

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1654 / 1655

页数：2

共 6 条

[1] Population estimation of the effects of cytochrome P4502C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese [J].

Goto, Shuji ;

Seo, Takayuki ;

Murata, Tsukasa ;

Nakada, Naoyuki ;

Ueda, Nao ;

Ishitsu, Takateru ;

Nakagawa, Kazuko .

THERAPEUTIC DRUG MONITORING, 2007, 29 (01) :118-121

[2] Ritonavir - Clinical pharmacokinetics and interactions with other anti-HIV agents [J].

Hsu, A ;

Granneman, GR ;

Bertz, RJ .

CLINICAL PHARMACOKINETICS, 1998, 35 (04) :275-291

[3] Tipranavir - A novel nonpeptidic protease inhibitor of HIV [J].

King, Jennifer R. ;

Acosta, Edward P. .

CLINICAL PHARMACOKINETICS, 2006, 45 (07) :665-682

[4] Anticonvulsant and antiretroviral interactions [J].

Liedtke, MD ;

Lockhart, SM ;

Rathbun, RC .

ANNALS OF PHARMACOTHERAPY, 2004, 38 (03) :482-489

[5] Coadministration of Lopinavir/Ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction [J].

Lim, ML ;

Min, SS ;

Eron, JJ ;

Bertz, RJ ;

Robinson, M ;

Gaedigk, A ;

Kashuba, ADM .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (05) :1034-1040

[6] Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir [J].

Vourvahis, Manoli ;

Kashuba, Angela D. M. .

PHARMACOTHERAPY, 2007, 27 (06) :888-909

← 1 →